AtriCure, a provider of Atrial Fibrillation (Afib) medical device, and Endoscopic Technologies, d/b/a Estech, have entered into a definitive merger agreement under which AtriCure has agreed to acquire Estech. Under the agreement, AtriCure ...
AtriCure, a developer of solutions to treat atrial fibrillation (Afib), has announced the US Food and Drug Administration’s (FDA) approval to begin enrollment in a clinical study of its AtriClip left atrial appendage exclusion system. ...
Tags: AtriCure, Stroke Prevention
The AtriCure has obtained the US Food and Drug Administration (FDA) clearance to commence three-year Ablate post approval study (PAS), designed for the surgical correction of atrial fibrillation. The 350 patient study is designed to ...
Tags: AtriCure, FDA clearance, post approval study, PAS, Synergy ablation system
AtriCure, a developer of cardiac surgical ablation systems, has named Michael Carrel as the company's new president and chief executive officer (CEO). Initially, Carrel served at Vital Images, a medical imaging software company, as ...
Tags: management team, new CEO, AtriCure